x 

0 Activities
0 Activities
    • No Saved Activities

Videos

  2. Home
  3. Education
  4. Format
  5. Videos
Page 3 of 4
Results 151 - 225 of 232
9907-0004_ip
Interstitial Pneumonia with Autoimmune Features
9907-0003_pf-ild
How to Identify Progressive Fibrosing ILD
9907-0002_ctd
When Is It a Connective Tissue Disease?
9907-0001_guidelines
How to Use IPF Guidelines to Make a Diagnosis
sma-icon
Are You Ready for Gene Replacement Therapy?
9916-kalluri
Advanced Care Planning and Palliative Care Models for Patients with IPF
9916-kalluri
Dyspnea Assessment in Patients with IPF
9916-scholand1
Which Patients with IPF Should be on Antifibrotics?
9916-brown5
The Impact of Anticoagulation Use on IPF Patient Outcomes
9916-brown5
Patient-Centered Outcomes for Patients with IPF: Activity Monitoring
9916-solomon
Connective Tissue Disease-Related ILD is Now in the Limelight
9916-brown5
Biomarkers in IPF and Other ILDs
curesma19-icon
The Changing Landscape of SMA–Updates from Anaheim, CA
New_Concepts_in_the_Pathobiology_of_Asthma_264x150
New Concepts in the Pathobiology of Asthma
9916-king
What are the Most Exciting Things Happening in Pulmonary Disease?
9916-scholand
New Tools to Improve the Diagnosis of IPF vs Other ILDs
9916-brown
New Research on Therapies for Patients with Pulmonary Fibrosis
9916-richeldi
The SENSCIS Trial: Exciting News for Scleroderma-Associated ILD
9916-cc-cme
2019 Summer Pulmonary Updates: The Experts Weigh In
9833-0001-icon
Urgency for Early Diagnosis and Treatment of SMA
med-doc-aatd
A Closer Look at Alpha-1 Antitrypsin Deficiency: Peggy’s Story
med-doc-ph
How Pulmonary Arterial Hypertension Has Changed Iain’s Life
9834-0002
SMA: Data, Insights and Practice
9829-0001
From Bench to Bedside: Gene Therapy Approaches for Rare Diseases
9816-0001
The Latest from a Recent Pulmonary Conference in San Antonio
9816-0010
Updates in Inoperable CTEPH
9816-0009
The Importance of Early Integration of Palliative Care
9816-0006
Management of IPF Patients in 2018
9816-0005
Updates in the Diagnosis of ILD and the Role of Cryobiopsy
9816-00045
Overview of the Latest Clinical Trials in IPF
9816-0003
Evolution of Antifibrotic Therapy in IPF
9816-0002
Take Home Messages from the 2018 CHEST Annual Meeting
9816-0008
What We’re Learning from the IPF-PRO Registry
9816-0007
Comparing the 2017 Fleischner Society Guidelines and the 2018 ATS Guidelines
NTM_and_Treatment_Strategies_for_Patients_264x150
NTM and Treatment Strategies for Patients with Cavitary Disease
New_Findings_in_the_Treatment_of_MAC_264x150
New Findings in the Treatment of MAC Lung Disease
Why_You_Should_Pay_Attention_to_NTM_264x150
Why You Should Pay Attention to NTM Treatment Guidelines
Which_of_Your_Patients_Are_at_Risk_for_NTM_264x150
Which of Your Patients Are at Risk for NTM?
Practice_Improvement_through_ILD_Centers_264x150
Practice Improvement through ILD Centers and Community Partnerships
Improving_the_Care_for_IPF_Patients_264x150
Improving the Care for IPF Patients Using a Team-Based Approach
An_Early_Integrated_Palliative_Care_264x150
An Early Integrated Palliative Care Delivery Model for Patients with IPF
asthma-uncontrol icon
A Personalized Approach to Managing Uncontrolled Asthma
Proper_Use_of_an_Inhaler_264x150
Proper Use of an Inhaler
No image set
Genetics and Personalized Medicine for Patients with Pulmonary Fibrosis
No image set
Environmental Influences on the Development of Pulmonary Fibrosis
No image set
Gene Abnormalities and ILD
No image set
Exploring the Basic Mechanisms that Contribute to Development of Lung Fibrosis
No image set
Updates on Registry Enrollment and Growth of the Care Center Network
No image set
New Approaches to the Diagnosis of IPF
No image set
Exploring New Therapeutic Avenues for Managing PF
No image set
New Research on Mechanisms in the Development of PF
No image set
Know Before You Go: IPF Grand Rounds Pre-learning
No image set
IPF Management Considerations
No image set
Perspectives on Side Effect Management
No image set
The Latest in IPF: Implications for Clinical Practice
No image set
Registry Data Provide Important Severity Indicators for PH
No image set
New Developments in the Diagnosis and Management of IPF
No image set
Palliative Care for Patients with IPF
No image set
Real World Experience in Patients with COPD
No image set
ICD-10 Codes and Nomenclature for Classification of PAH
No image set
Fleischner Society Update in Classification of IPF
No image set
Transbronchial Cryobiopsy for the Diagnosis of ILD
No image set
The Importance of Early Referral and Treatment
No image set
How to Recognize and Diagnose IPF
No image set
What Is IPF?
No image set
What’s Next for IPF Therapy?
No image set
Applying the Evidence on Antifibrotic Agents for IPF
No image set
What Do the Experts Say about New Developments in the Diagnosis of ILD?
No image set
Is the delivery system a good match for your patients with COPD?
No image set
Stepping up or stepping down – which direction for COPD patients?
No image set
What’s the 2017 GOLD standard for managing patients with COPD?
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Individualizing Patient Education in Treatment Choice: Practical Strategies
No image set
Discovering New Drugs for IPF
No image set
Biomarkers for IPF
Page 3 of 4

Search